HLT Stock Analysis: Hilton Worldwide Holdings | NYSE
Lodging | NYSE, USA | Market Cap: 74.179m USD | 12M Return: 29.6% | US43300A2033 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 461M
EPS Trend: 99.7%
Qual. Beats: 0
Rev. Trend: 99.7%
Qual. Beats: 0
Warnings
Tailwinds
No distinct edge detected
Seasonality 11.7 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Hilton Worldwide Holdings Inc. (NYSE: HLT) is a global hospitality company that manages, franchises, and leases hotels and resorts through two operating segments: Management and Franchise, and Ownership. The companys core business revolves around licensing its brand names, trademarks, and service marks to hotel operators, rather than primarily owning the underlying real estate.
Hilton operates an extensive brand portfolio spanning luxury (Waldorf Astoria, LXR, Conrad), lifestyle (Canopy, Graduate, Tempo, Motto, NoMad), full service (Hilton Hotels & Resorts, DoubleTree, Curio Collection, Tapestry Collection, Embassy Suites), focused service (Hilton Garden Inn, Hampton, Tru, Spark, Home2 Suites), and timeshare (Hilton Grand Vacations) categories. Its Hilton Honors loyalty program supports guest retention across the portfolio.
The company maintains a global footprint across North America, South America, Central America (including the Caribbean), Europe, the Middle East, Africa, and Asia Pacific. Founded in 1919 and headquartered in McLean, Virginia, Hilton is classified as a large-cap stock in the Consumer Discretionary sector within the Hotels, Resorts & Cruise Lines sub-industry, having gone public on the NYSE in December 2013.
- RevPAR declines as US leisure travel demand softens
- Record development pipeline accelerates global unit expansion
- Asset-light franchise model drives margin expansion
| Net Income: 1.58b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.12 > 0.02 and ΔFCF/TA -1.96 > 1.0 |
| NWC/Revenue: -14.27% < 20% (prev -18.43%; Δ 4.16% < -1%) |
| CFO/TA 0.12 > 3% & CFO 2.11b > Net Income 1.58b |
| Net Debt (13.7b) to EBITDA (3.09b): 4.43 < 3 |
| Current Ratio: 0.65 > 1.5 & < 3 |
| Outstanding Shares: last quarter (229.0m) vs 12m ago -4.18% < -2% |
| Gross Margin: 44.06% > 18% (prev 27.09%; Δ 16.97% > 0.5%) |
| Asset Turnover: 76.05% > 50% (prev 72.20%; Δ 3.86% > 0%) |
| Interest Coverage Ratio: 4.34 > 6 (EBIT TTM 2.90b / Interest Expense TTM 669.0m) |
| A: -0.11 (Total Current Assets 3.29b - Total Current Liabilities 5.08b) / Total Assets 16.9b |
| B: -0.04 (Retained Earnings -710.0m / Total Assets 16.9b) |
| C: 0.18 (EBIT TTM 2.90b / Avg Total Assets 16.4b) |
| D: -0.27 (Book Value of Equity -6.30b / Total Liabilities 23.2b) |
| Altman-Z'' = 0.08 = B |
| DSRI: 0.98 (Receivables 1.79b/1.68b, Revenue 12.5b/11.5b) |
| GMI: 0.61 (GM 27.09% / 44.06%) |
| AQI: 0.94 (AQ_t 0.73 / AQ_t-1 0.78) |
| SGI: 1.09 (Revenue 12.5b / 11.5b) |
| TATA: -0.03 (NI 1.58b - CFO 2.11b) / TA 16.9b) |
| Beneish M = -3.37 (Cap -4..+1) = AA |
As of October 16, 2026, the stock is trading at USD 342.98 with a total of 1,880,489 shares traded. Over the past week, the price has changed by +6.09%, over one month by +11.43%, over three months by +4.46% and over the past year by +29.63%.
Current recommended Stop Loss: 334.70 (which is 2.4% or 1.4 ATR below the current price).
Hilton Worldwide Holdings has received a consensus analysts rating of 4.04. Therefore, it is recommended to buy HLT.
- StrongBuy: 13
- Buy: 4
- Hold: 10
- Sell: 1
- StrongSell: 0
| Analysts Target Price | 353.2 | 3% |
P/E Trailing = 48.327
P/E Forward = 28.7356
P/S = 14.5335
P/B = 277.4118
P/EG = 1.2704
Revenue TTM = 12.5b USD
EBIT TTM = 2.90b USD
EBITDA TTM = 3.09b USD
Long Term Debt = 12.7b USD (from longTermDebt, last quarter)
Short Term Debt = 624.0m USD (from shortTermDebt, last quarter)
Debt = 14.7b USD (from shortLongTermDebtTotal, last quarter) + Leases 680.0m
Net Debt = 13.7b USD (calculated: Debt 14.7b - CCE 1.01b)
Enterprise Value = 87.9b USD (74.2b + Debt 14.7b - CCE 1.01b)
Interest Coverage Ratio = 4.34 (Ebit TTM 2.90b / Interest Expense TTM 669.0m)
EV/FCF = 43.78x (Enterprise Value 87.9b / FCF TTM 2.01b)
FCF Yield = 2.28% (FCF TTM 2.01b / Enterprise Value 87.9b)
FCF Margin = 16.08% (FCF TTM 2.01b / Revenue TTM 12.5b)
Net Margin = 12.69% (Net Income TTM 1.58b / Revenue TTM 12.5b)
Gross Margin = 44.06% ((Revenue TTM 12.5b - Cost of Revenue TTM 6.98b) / Revenue TTM)
Gross Margin QoQ = 30.47% (prev 40.25%)
Tobins Q-Ratio = 5.19 (Enterprise Value 87.9b / Total Assets 16.9b)
Interest Expense / Debt = 4.55% (Interest Expense 669.0m / Debt 14.7b)
Taxrate = 29.18% (651.0m / 2.23b)
NOPAT = 2.05b (EBIT 2.90b * (1 - 29.18%))
Current Ratio = 0.65 (Total Current Assets 3.29b / Total Current Liabilities 5.08b)
Debt / Equity = -2.33 (negative equity) (Debt 14.7b / totalStockholderEquity, last quarter -6.30b)
Debt / EBITDA = 4.43 (Net Debt 13.7b / EBITDA 3.09b)
Debt / FCF = 6.82 (Net Debt 13.7b / FCF TTM 2.01b)
Total Stockholder Equity = -5.63b (last 4 quarters mean from totalStockholderEquity)
RoA = 9.65% (Net Income 1.58b / Total Assets 16.9b)
RoE = -28.12% (negative equity) (Net Income TTM 1.58b / Total Stockholder Equity -5.63b)
RoCE = 40.93% (EBIT 2.90b / Capital Employed (Equity -5.63b + L.T.Debt 12.7b))
RoIC = 17.33% (NOPAT 2.05b / Invested Capital 11.9b)
WACC = 7.74% (E(74.2b)/V(88.9b) * Re(8.63%) + D(14.7b)/V(88.9b) * Rd(4.55%) * (1-Tc(0.29)))
Discount Rate = 8.63% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -98.75 | Cagr: -4.67%
[DCF] Terminal Value 74.17% ; FCFF base≈2.08b ; Y1≈1.94b ; Y5≈1.77b
[DCF] Fair Price = 63.25 (EV 27.9b - Net Debt 13.7b = Equity 14.2b / Shares 225.1m; r=8.35% [WACC [floored]]; 5y FCF grow -8.69% → 2.50% )
EPS Correlation: 99.65 | EPS CAGR: 13.05% | SUE: 0.0 | # QB: 0
Revenue Correlation: 99.70 | Revenue CAGR: 8.00% | SUE: 0.35 | # QB: 0
EPS current Quarter (2026-09-30): EPS=2.35 | Chg30d=+0.00% | Revisions=-29% | Analysts=22
EPS current Year (2026-12-31): EPS=9.05 | Chg30d=+0.10% | Revisions=+12% | GrowthEPS=+11.6% | GrowthRev=+8.2%
EPS next Year (2027-12-31): EPS=10.45 | Chg30d=-0.02% | Revisions=+12% | GrowthEPS=+15.5% | GrowthRev=+8.6%
[Analyst] Revisions Ratio: +0% (up=7, down=7)